Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Lisa Maier to Alleles

This is a "connection" page, showing publications Lisa Maier has written about Alleles.

 
Connection Strength
 
 
 
0.801
 
  1. Silveira LJ, McCanlies EC, Fingerlin TE, Van Dyke MV, Mroz MM, Strand M, Fontenot AP, Bowerman N, Dabelea DM, Schuler CR, Weston A, Maier LA. Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove. J Immunol. 2012 Oct 15; 189(8):4014-23.
    View in: PubMed
    Score: 0.390
  2. Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med. 2011 Jun 15; 183(12):1680-8.
    View in: PubMed
    Score: 0.088
  3. Pacheco KA, Rose CS, Silveira LJ, Van Dyke MV, Goelz K, MacPhail K, Maier LA. Gene-environment interactions influence airways function in laboratory animal workers. J Allergy Clin Immunol. 2010 Aug; 126(2):232-40.
    View in: PubMed
    Score: 0.084
  4. Sato H, Spagnolo P, Silveira L, Welsh KI, du Bois RM, Newman LS, Maier LA. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals. Tissue Antigens. 2007 Dec; 70(6):480-6.
    View in: PubMed
    Score: 0.069
  5. Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J Immunol. 1999 Aug 01; 163(3):1647-53.
    View in: PubMed
    Score: 0.039
  6. Maier LA, Raynolds MV, Young DA, Barker EA, Newman LS. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med. 1999 Apr; 159(4 Pt 1):1342-50.
    View in: PubMed
    Score: 0.038
  7. Liu B, Maier LA, Hamzeh N, MacPhail K, Mroz MM, Liu H, Li L. Polymorphism of FCGR3A gene in chronic beryllium disease. Genes Immun. 2019 07; 20(6):493-499.
    View in: PubMed
    Score: 0.037
  8. Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM, Maier LA, Newman LS, Nagai S, Izumi T, Wells AU, du Bois RM, Welsh KI. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet. 2010 Oct 15; 19(20):4100-11.
    View in: PubMed
    Score: 0.021
  9. Pacheco K, Maier L, Silveira L, Goelz K, Noteware K, Luna B, du Bois R, Murphy J, Rose C. Association of Toll-like receptor 4 alleles with symptoms and sensitization to laboratory animals. J Allergy Clin Immunol. 2008 Nov; 122(5):896-902.e4.
    View in: PubMed
    Score: 0.019
  10. Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. J Immunol. 2005 Nov 15; 175(10):7029-37.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)